John Suliman

Experience

• 

  Co-Founder

  Shape Therapeutics, Inc. • Current • Apr 2018 - Present

  ShapeTX is pioneering the field of programmable RNA medicines to repair the genetic causes of diseases. By merging innovations in AI and RNA technology to generate and analyze hundreds of billions of therapeutic possibilities, ShapeTX is developing breakthroughs in RNA editing, next-generation AAVs, and disruptive gene therapy manufacturing. The ShapeTX…

• Founder Investor

  Step Partners • Current • Sep 2012 - Present

• Additional experience 1
• Additional experience 2